Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of ABCB1 in Non-small Cell Lung Cancer.
Hayashi A, Kamio K, Miyanaga A, Yoshida K, Noro R, Matsuda K, Tozuka T, Omori M, Hirao M, Fukuizumi A, Hisakane K, Takeuchi S, Matsumoto M, Kasahara K, Amano T, Honda K, Seike M. Hayashi A, et al. Among authors: fukuizumi a. Anticancer Res. 2024 Dec;44(12):5271-5282. doi: 10.21873/anticanres.17355. Anticancer Res. 2024. PMID: 39626921
IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.
Terashima Y, Matsumoto M, Ozaki S, Nakagawa M, Nakagome S, Terasaki Y, Iida H, Mitsugi R, Kuramochi E, Okada N, Inoue T, Matsuki S, Kitagawa S, Fukuizumi A, Onda N, Takeuchi S, Miyanaga A, Kasahara K, Seike M. Terashima Y, et al. Among authors: fukuizumi a. Front Immunol. 2024 Aug 14;15:1370972. doi: 10.3389/fimmu.2024.1370972. eCollection 2024. Front Immunol. 2024. PMID: 39206190 Free PMC article.
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC.
Terashima Y, Matsumoto M, Iida H, Takashima S, Fukuizumi A, Takeuchi S, Miyanaga A, Terasaki Y, Kasahara K, Seike M. Terashima Y, et al. Among authors: fukuizumi a. JTO Clin Res Rep. 2023 Sep 21;4(11):100578. doi: 10.1016/j.jtocrr.2023.100578. eCollection 2023 Nov. JTO Clin Res Rep. 2023. PMID: 37885809 Free PMC article.
Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility study.
Omori M, Minegishi Y, Uruga H, Fukuizumi A, Isobe K, Izumi S, Koyama R, Bando M, Sugiyama H, Takahashi K, Gemma A, Homma S, Sugiyama Y, Kishi K. Omori M, et al. Among authors: fukuizumi a. Respir Investig. 2023 Sep;61(5):625-631. doi: 10.1016/j.resinv.2023.06.002. Epub 2023 Jul 11. Respir Investig. 2023. PMID: 37441903 Clinical Trial.
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma.
Takahashi A, Noro R, Takano N, Hisakane K, Takahashi S, Fukuizumi A, Omori M, Sugano T, Takeuchi S, Nakamichi S, Miyanaga A, Minegishi Y, Kubota K, Seike M, Gemma A. Takahashi A, et al. Among authors: fukuizumi a. Mol Clin Oncol. 2022 Apr;16(4):87. doi: 10.3892/mco.2022.2520. Epub 2022 Feb 21. Mol Clin Oncol. 2022. PMID: 35251638 Free PMC article.
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.
Fukuizumi A, Noro R, Seike M, Miyanaga A, Minegishi Y, Omori M, Hirao M, Matsuda K, Kunugi S, Nishiwaki K, Morimoto M, Motohashi H, Ohwada H, Usuda J, Gemma A. Fukuizumi A, et al. JTO Clin Res Rep. 2021 Sep 24;2(11):100232. doi: 10.1016/j.jtocrr.2021.100232. eCollection 2021 Nov. JTO Clin Res Rep. 2021. PMID: 34746885 Free PMC article.
Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy.
Okuma Y, Ko R, Shukuya T, Tateishi K, Imai H, Iwasawa S, Miyauchi E, Kojima T, Fujita Y, Hino T, Yamanda S, Suzuki T, Fukuizumi A, Sakakibara T, Harada T, Morita S, Kobayashi K, Nukiwa T, Takahashi K; North East Japan Study Group. Okuma Y, et al. Among authors: fukuizumi a. Lung Cancer. 2020 Oct;148:122-128. doi: 10.1016/j.lungcan.2020.08.014. Epub 2020 Aug 20. Lung Cancer. 2020. PMID: 32890794
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.
Fukuizumi A, Minegishi Y, Omori M, Atsumi K, Takano N, Hisakane K, Takahashi S, Kobayashi K, Sugano T, Takeuchi S, Noro R, Seike M, Kubota K, Azuma A, Gemma A. Fukuizumi A, et al. Int J Clin Oncol. 2019 Dec;24(12):1543-1548. doi: 10.1007/s10147-019-01516-9. Epub 2019 Jul 27. Int J Clin Oncol. 2019. PMID: 31352631 Clinical Trial.
12 results